Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 192

1.

Access, knowledge and experience with FDG-PET/CT in infection management: a survey of Australia and New Zealand infectious diseases physicians and microbiologists.

Douglas AP, Thursky KA, Worth LJ, Harrison SJ, Hicks RJ, Slavin MA.

Intern Med J. 2018 Sep 19. doi: 10.1111/imj.14117. [Epub ahead of print]

PMID:
30230669
2.

The pharmacokinetics and pharmacodynamics of busulfan when combined with melphalan as conditioning in adult autologous stem cell transplant recipients.

Willcox A, Wong E, Nath C, Janson B, Harrison SJ, Hoyt R, Bajel A, Shaw P, Ritchie D, Grigg A.

Ann Hematol. 2018 Dec;97(12):2509-2518. doi: 10.1007/s00277-018-3447-x. Epub 2018 Jul 26.

PMID:
30051172
3.

When Coordinating Finger Tapping to a Variable Beat the Variability Scaling Structure of the Movement and the Cortical BOLD Signal are Both Entrained to the Auditory Stimuli.

Harrison SJ, Hough M, Schmid K, Groff BR, Stergiou N.

Neuroscience. 2018 Nov 10;392:203-218. doi: 10.1016/j.neuroscience.2018.06.025. Epub 2018 Jun 27.

PMID:
29958941
4.

Using temporal ICA to selectively remove global noise while preserving global signal in functional MRI data.

Glasser MF, Coalson TS, Bijsterbosch JD, Harrison SJ, Harms MP, Anticevic A, Van Essen DC, Smith SM.

Neuroimage. 2018 Nov 1;181:692-717. doi: 10.1016/j.neuroimage.2018.04.076. Epub 2018 Aug 2.

PMID:
29753843
5.

Multi-subject hierarchical inverse covariance modelling improves estimation of functional brain networks.

Colclough GL, Woolrich MW, Harrison SJ, Rojas López PA, Valdes-Sosa PA, Smith SM.

Neuroimage. 2018 Sep;178:370-384. doi: 10.1016/j.neuroimage.2018.04.077. Epub 2018 May 7.

6.

Serum metabolomics using ultra performance liquid chromatography coupled to mass spectrometry in lactating dairy cows following a single dose of sporidesmin.

Matthews ZM, Edwards PJB, Kahnt A, Collett MG, Marshall JC, Partridge AC, Harrison SJ, Fraser K, Cao M, Derrick PJ.

Metabolomics. 2018;14(5):61. doi: 10.1007/s11306-018-1358-4. Epub 2018 Apr 17.

7.

Enumeration, functional responses and cytotoxic capacity of MAIT cells in newly diagnosed and relapsed multiple myeloma.

Gherardin NA, Loh L, Admojo L, Davenport AJ, Richardson K, Rogers A, Darcy PK, Jenkins MR, Prince HM, Harrison SJ, Quach H, Fairlie DP, Kedzierska K, McCluskey J, Uldrich AP, Neeson PJ, Ritchie DS, Godfrey DI.

Sci Rep. 2018 Mar 7;8(1):4159. doi: 10.1038/s41598-018-22130-1.

8.

The relationship between spatial configuration and functional connectivity of brain regions.

Bijsterbosch JD, Woolrich MW, Glasser MF, Robinson EC, Beckmann CF, Van Essen DC, Harrison SJ, Smith SM.

Elife. 2018 Feb 16;7. pii: e32992. doi: 10.7554/eLife.32992.

9.

Considerations for pre-transfusion immunohaematology testing in patients receiving the anti-CD38 monoclonal antibody daratumumab for the treatment of multiple myeloma.

Quach H, Benson S, Haysom H, Wilkes AM, Zacher N, Cole-Sinclair M, Miles Prince H, Mollee P, Spencer A, Joy Ho P, Harrison SJ, Lee C, Augustson B, Daly J.

Intern Med J. 2018 Feb;48(2):210-220. doi: 10.1111/imj.13707. Review.

PMID:
29415351
10.

Predicting Risk of Infection in Patients with Newly Diagnosed Multiple Myeloma: Utility of Immune Profiling.

Teh BW, Harrison SJ, Allison CC, Slavin MA, Spelman T, Worth LJ, Thursky KA, Ritchie D, Pellegrini M.

Front Immunol. 2017 Oct 5;8:1247. doi: 10.3389/fimmu.2017.01247. eCollection 2017.

11.

Vox Sanguinis International Forum on provision of granulocytes for transfusion and their clinical use.

Morton S, Stanworth S, Lozano M, Harrison SJ, Hong FS, Dennington P, McQuilten Z, Worel N, Compernolle V, Kutner JM, Yokoyama APH, Nahirniak S, Germain M, Hume H, Robitaille N, Wilson A, Tinmouth A, Massey E, Boulat C, Woimant G, Tiberghien P, Schulze TJ, Bux J, Pierelli L, Ballester C, Netelenbos T, West KA, Conry-Cantilena C, Eder A, Haley NR, Yazer M, Triulzi D.

Vox Sang. 2017 Oct;112(7):e48-e68. doi: 10.1111/vox.12523. Epub 2017 Sep 14. No abstract available.

PMID:
28905396
12.

Vox Sanguinis International Forum on provision of granulocytes for transfusion and their clinical use: summary.

Morton S, Stanworth S, Lozano M, Harrison SJ, Hong FS, Dennington P, McQuilten Z, Worel N, Compernolle V, Kutner JM, Yokoyama APH, Nahirniak S, Germain M, Hume H, Robitaille N, Wilson A, Tinmouth A, Massey E, Boulat C, Woimant G, Tiberghien P, Schulze TJ, Bux J, Pierelli L, Ballester C, Netelenbos T, West KA, Conry-Cantilena C, Eder A, Haley NR, Yazer M, Triulzi D.

Vox Sang. 2017 Oct;112(7):680-683. doi: 10.1111/vox.12522. Epub 2017 Sep 14. No abstract available.

PMID:
28905391
13.

Promising efficacy and acceptable safety of venetoclax plus bortezomib and dexamethasone in relapsed/refractory MM.

Moreau P, Chanan-Khan A, Roberts AW, Agarwal AB, Facon T, Kumar S, Touzeau C, Punnoose EA, Cordero J, Munasinghe W, Jia J, Salem AH, Freise KJ, Leverson JD, Enschede SH, Ross JA, Maciag PC, Verdugo M, Harrison SJ.

Blood. 2017 Nov 30;130(22):2392-2400. doi: 10.1182/blood-2017-06-788323. Epub 2017 Aug 28.

14.

Building a fructan LC-MS2 library and its application to reveal the fine structure of cereal grain fructans.

Verspreet J, Hansen AH, Harrison SJ, Vergauwen R, Van den Ende W, Courtin CM.

Carbohydr Polym. 2017 Oct 15;174:343-351. doi: 10.1016/j.carbpol.2017.06.063. Epub 2017 Jun 19.

PMID:
28821077
15.

To Pass or Not to Pass: Modeling the Movement and Affordance Dynamics of a Pick and Place Task.

Lamb M, Kallen RW, Harrison SJ, Di Bernardo M, Minai A, Richardson MJ.

Front Psychol. 2017 Jun 28;8:1061. doi: 10.3389/fpsyg.2017.01061. eCollection 2017.

16.

Are Albumin Levels a Good Predictor of Mortality in Elderly Patients with Neck of Femur Fractures?

Harrison SJ, Messner J, Leeder DJ, Stephenson J, Sidhom SA.

J Nutr Health Aging. 2017;21(6):699-703. doi: 10.1007/s12603-016-0799-6.

PMID:
28537335
17.

Multiple myeloma of the spine.

Lasocki A, Gaillard F, Harrison SJ.

Neuroradiol J. 2017 Jun;30(3):259-268. doi: 10.1177/1971400917699426. Epub 2017 Apr 20. Review.

18.

Retrospective review of patients with atypical bisphosphonate related proximal femoral fractures.

Phillips HK, Harrison SJ, Akrawi H, Sidhom SA.

Injury. 2017 Jun;48(6):1159-1164. doi: 10.1016/j.injury.2017.03.025. Epub 2017 Apr 4.

PMID:
28410753
19.

Inhibition of Pol I transcription treats murine and human AML by targeting the leukemia-initiating cell population.

Hein N, Cameron DP, Hannan KM, Nguyen NN, Fong CY, Sornkom J, Wall M, Pavy M, Cullinane C, Diesch J, Devlin JR, George AJ, Sanij E, Quin J, Poortinga G, Verbrugge I, Baker A, Drygin D, Harrison SJ, Rozario JD, Powell JA, Pitson SM, Zuber J, Johnstone RW, Dawson MA, Guthridge MA, Wei A, McArthur GA, Pearson RB, Hannan RD.

Blood. 2017 May 25;129(21):2882-2895. doi: 10.1182/blood-2016-05-718171. Epub 2017 Mar 10.

20.

De-bugging and maximizing plant cytochrome P450 production in Escherichia coli with C-terminal GFP fusions.

Christensen U, Vazquez-Albacete D, Søgaard KM, Hobel T, Nielsen MT, Harrison SJ, Hansen AH, Møller BL, Seppälä S, Nørholm MHH.

Appl Microbiol Biotechnol. 2017 May;101(10):4103-4113. doi: 10.1007/s00253-016-8076-5. Epub 2017 Feb 15.

PMID:
28204885
21.

T-cell acute leukaemia exhibits dynamic interactions with bone marrow microenvironments.

Hawkins ED, Duarte D, Akinduro O, Khorshed RA, Passaro D, Nowicka M, Straszkowski L, Scott MK, Rothery S, Ruivo N, Foster K, Waibel M, Johnstone RW, Harrison SJ, Westerman DA, Quach H, Gribben J, Robinson MD, Purton LE, Bonnet D, Lo Celso C.

Nature. 2016 Oct 27;538(7626):518-522. doi: 10.1038/nature19801. Epub 2016 Oct 17.

22.

Functional mining of transporters using synthetic selections.

Genee HJ, Bali AP, Petersen SD, Siedler S, Bonde MT, Gronenberg LS, Kristensen M, Harrison SJ, Sommer MO.

Nat Chem Biol. 2016 Dec;12(12):1015-1022. doi: 10.1038/nchembio.2189. Epub 2016 Oct 3.

PMID:
27694800
23.

Identification and validation of novel small proteins in Pseudomonas putida.

Yang X, Jensen SI, Wulff T, Harrison SJ, Long KS.

Environ Microbiol Rep. 2016 Dec;8(6):966-974. doi: 10.1111/1758-2229.12473. Epub 2016 Oct 13.

PMID:
27717237
24.

Epidemiology of bloodstream infections in patients with myeloma receiving current era therapy.

Teh BW, Harrison SJ, Slavin MA, Worth LJ.

Eur J Haematol. 2017 Feb;98(2):149-153. doi: 10.1111/ejh.12813. Epub 2016 Oct 10.

PMID:
27717026
25.

Spontaneous onset and transplant models of the Vk*MYC mouse show immunological sequelae comparable to human multiple myeloma.

Cooke RE, Gherardin NA, Harrison SJ, Quach H, Godfrey DI, Prince M, Koldej R, Ritchie DS.

J Transl Med. 2016 Sep 6;14:259. doi: 10.1186/s12967-016-0994-6.

26.

Infection risk with immunomodulatory and proteasome inhibitor-based therapies across treatment phases for multiple myeloma: A systematic review and meta-analysis.

Teh BW, Harrison SJ, Worth LJ, Thursky KA, Slavin MA.

Eur J Cancer. 2016 Nov;67:21-37. doi: 10.1016/j.ejca.2016.07.025. Epub 2016 Sep 1. Review.

PMID:
27592069
27.

Update and new approaches in the treatment of Castleman disease.

Chan KL, Lade S, Prince HM, Harrison SJ.

J Blood Med. 2016 Aug 3;7:145-58. doi: 10.2147/JBM.S60514. eCollection 2016. Review.

28.

Physical Activity Preferences for People Living With Multiple Myeloma: A Qualitative Study.

Craike M, Hose K, Courneya KS, Harrison SJ, Livingston PM.

Cancer Nurs. 2017 Sep/Oct;40(5):E1-E8. doi: 10.1097/NCC.0000000000000425.

PMID:
27532741
29.

Marizomib irreversibly inhibits proteasome to overcome compensatory hyperactivation in multiple myeloma and solid tumour patients.

Levin N, Spencer A, Harrison SJ, Chauhan D, Burrows FJ, Anderson KC, Reich SD, Richardson PG, Trikha M.

Br J Haematol. 2016 Sep;174(5):711-20. doi: 10.1111/bjh.14113. Epub 2016 May 9.

30.

Phase I Clinical Trial of Marizomib (NPI-0052) in Patients with Advanced Malignancies Including Multiple Myeloma: Study NPI-0052-102 Final Results.

Harrison SJ, Mainwaring P, Price T, Millward MJ, Padrik P, Underhill CR, Cannell PK, Reich SD, Trikha M, Spencer A.

Clin Cancer Res. 2016 Sep 15;22(18):4559-66. doi: 10.1158/1078-0432.CCR-15-2616. Epub 2016 Apr 26.

31.

Engraftment syndrome manifesting as acute brachial neuropathy following high-dose chemotherapy for management of plasma cell myeloma.

Ninkovic S, Cheah CY, Lasocki A, Harrison SJ.

Leuk Lymphoma. 2016 Dec;57(12):2942-2945. Epub 2016 Apr 27. No abstract available.

PMID:
27116896
32.

Myeloma of the central nervous system - an ongoing conundrum!

Harrison SJ, Spencer A, Quach H.

Leuk Lymphoma. 2016 Jul;57(7):1505-6. doi: 10.3109/10428194.2016.1154961. Epub 2016 Mar 21. No abstract available.

PMID:
26999494
33.

Optimization of tetrahydronaphthalene inhibitors of Raf with selectivity over hERG.

Huang SC, Adhikari S, Afroze R, Brewer K, Calderwood EF, Chouitar J, England DB, Fisher C, Galvin KM, Gaulin J, Greenspan PD, Harrison SJ, Kim MS, Langston SP, Ma LT, Menon S, Mizutani H, Rezaei M, Smith MD, Zhang DM, Gould AE.

Bioorg Med Chem Lett. 2016 Feb 15;26(4):1156-60. doi: 10.1016/j.bmcl.2016.01.049. Epub 2016 Jan 21.

PMID:
26804230
34.

Identified metabolic signature for assessing red blood cell unit quality is associated with endothelial damage markers and clinical outcomes.

Bordbar A, Johansson PI, Paglia G, Harrison SJ, Wichuk K, Magnusdottir M, Valgeirsdottir S, Gybel-Brask M, Ostrowski SR, Palsson S, Rolfsson O, Sigurjónsson OE, Hansen MB, Gudmundsson S, Palsson BO.

Transfusion. 2016 Apr;56(4):852-62. doi: 10.1111/trf.13460. Epub 2016 Jan 8.

PMID:
26749434
35.

Antiviral prophylaxis for varicella zoster virus infections in patients with myeloma in the era of novel therapies.

Teh BW, Harrison SJ, Worth LJ, Slavin MA.

Leuk Lymphoma. 2016 Jul;57(7):1719-22. doi: 10.3109/10428194.2015.1106538. Epub 2016 Jan 4. No abstract available.

PMID:
26727243
36.

The Perspectives of Haematological Cancer Patients on Tissue Banking.

Turon H, Waller A, Clinton-McHarg T, Boyes A, Fleming J, Marlton P, Harrison SJ, Sanson-Fisher R.

Oncol Ther. 2016;4(1):91-102. doi: 10.1007/s40487-016-0019-x. Epub 2016 May 3.

37.

Glucose-based microbial production of the hormone melatonin in yeast Saccharomyces cerevisiae.

Germann SM, Baallal Jacobsen SA, Schneider K, Harrison SJ, Jensen NB, Chen X, Stahlhut SG, Borodina I, Luo H, Zhu J, Maury J, Forster J.

Biotechnol J. 2016 May;11(5):717-24. doi: 10.1002/biot.201500143. Epub 2016 Jan 25.

38.

Plasmacytoma of the testis in a patient with relapsed and refractory multiple myeloma: Case report and review of the literature.

Khan M, Rajarubendra N, Azer S, Skene A, Harrison SJ, Campbell B, Lawrentschuk N.

Urol Ann. 2015 Oct-Dec;7(4):530-3. doi: 10.4103/0974-7796.164844.

39.

Global measures of peripheral blood-derived DNA methylation as a risk factor in the development of mature B-cell neoplasms.

Wong Doo N, Makalic E, Joo JE, Vajdic CM, Schmidt DF, Wong EM, Jung CH, Severi G, Park DJ, Chung J, Baglietto L, Prince HM, Seymour JF, Tam C, Hopper JL, English DR, Milne RL, Harrison SJ, Southey MC, Giles GG.

Epigenomics. 2016 Jan;8(1):55-66. doi: 10.2217/epi.15.97. Epub 2015 Dec 18.

PMID:
26679037
40.

Prevention of viral infections in patients with multiple myeloma: the role of antiviral prophylaxis and immunization.

Teh BW, Slavin MA, Harrison SJ, Worth LJ.

Expert Rev Anti Infect Ther. 2015;13(11):1325-36. doi: 10.1586/14787210.2015.1083858. Epub 2015 Aug 31. Review.

PMID:
26489539
41.

Complex Adaptive Behavior and Dexterous Action.

Harrison SJ, Stergiou N.

Nonlinear Dynamics Psychol Life Sci. 2015 Oct;19(4):345-94. Review.

42.

Comment on "Retrospective matched-pairs analysis of bortezomib plus dexamethasone versus bortezomib monotherapy in relapsed multiple myeloma".

Harrison SJ, Quach H, Spencer A, Prince HM.

Haematologica. 2015 Sep;100(9):e379. doi: 10.3324/haematol.2015.128470. No abstract available.

43.

Ceritinib in patients with advanced anaplastic lymphoma kinase-rearranged anaplastic large-cell lymphoma.

Richly H, Kim TM, Schuler M, Kim DW, Harrison SJ, Shaw AT, Boral AL, Yovine A, Solomon B.

Blood. 2015 Sep 3;126(10):1257-8. doi: 10.1182/blood-2014-12-617779. No abstract available.

44.

Assembly of a novel biosynthetic pathway for production of the plant flavonoid fisetin in Escherichia coli.

Stahlhut SG, Siedler S, Malla S, Harrison SJ, Maury J, Neves AR, Forster J.

Metab Eng. 2015 Sep;31:84-93. doi: 10.1016/j.ymben.2015.07.002. Epub 2015 Jul 17.

45.

CrEdit: CRISPR mediated multi-loci gene integration in Saccharomyces cerevisiae.

Ronda C, Maury J, Jakočiunas T, Jacobsen SA, Germann SM, Harrison SJ, Borodina I, Keasling JD, Jensen MK, Nielsen AT.

Microb Cell Fact. 2015 Jul 7;14:97. doi: 10.1186/s12934-015-0288-3.

46.

Outcome of the Stryker® Trident 'All-Poly' constraint acetabular insert: a district general hospital experience.

Harrison SJ, Leeder DJ, McWilliams TG, Metcalf RW, Sidhom SA.

Hip Int. 2015 Nov-Dec;25(6):557-62. doi: 10.5301/hipint.5000263. Epub 2015 Jun 22.

PMID:
26109154
47.

Risks, severity and timing of infections in patients with multiple myeloma: a longitudinal cohort study in the era of immunomodulatory drug therapy.

Teh BW, Harrison SJ, Worth LJ, Spelman T, Thursky KA, Slavin MA.

Br J Haematol. 2015 Oct;171(1):100-8. doi: 10.1111/bjh.13532. Epub 2015 Jun 24.

PMID:
26105211
48.

Spatial specificity and inheritance of adaptation in human visual cortex.

Larsson J, Harrison SJ.

J Neurophysiol. 2015 Aug;114(2):1211-26. doi: 10.1152/jn.00167.2015. Epub 2015 Jun 10.

49.

Intracranial involvement by multiple myeloma.

Lasocki A, Gangatharan S, Gaillard F, Harrison SJ.

Clin Radiol. 2015 Aug;70(8):890-7. doi: 10.1016/j.crad.2015.03.014. Epub 2015 May 5. Review.

PMID:
25956664
50.

Light therapy and serotonin transporter binding in the anterior cingulate and prefrontal cortex.

Harrison SJ, Tyrer AE, Levitan RD, Xu X, Houle S, Wilson AA, Nobrega JN, Rusjan PM, Meyer JH.

Acta Psychiatr Scand. 2015 Nov;132(5):379-88. doi: 10.1111/acps.12424. Epub 2015 Apr 17.

Supplemental Content

Loading ...
Support Center